P3 Health Partners Inc
For the period ended Mar 31, 2024. Filed May 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 8, 2024
PIII$4.25+6.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber · Description · Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Form · File No. · Exhibit · Filing Date | ||||||
| 2.1 | Agreement and Plan of Merger, dated as of May 25, 2021, by and between Foresight Acquisition Corp., P3 Health Group Holdings, LLC and FAC Merger Sub LLC. | 8-K | 001-40033 | 2.1 | 6/1/2021 | |
| 2.2 | Transaction and Combination Agreement, dated as of May 25, 2021, by and among Foresight Acquisition Corp., the Merger Corps, the Blockers, Splitter and the Blocker Sellers. | 8-K | 001-40033 | 2.2 | 6/1/2021 | |
| 2.3 | First Amendment to Merger Agreement, dated as of November 21, 2021, by and among Foresight Acquisition Corp., FAC Merger Sub LLC and P3 Health Group Holdings, LLC. | 8-K | 001-40033 | 2.1 | 11/22/2021 | |
| 2.4 | Second Amendment, dated as of December 3, 2021, to the Agreement and Plan of Merger, dated as of May 25, 2021, by and among Foresight Acquisition Corp., FAC Merger Sub LLC and P3 Health Group Holdings, LLC. | 8-K | 001-40033 | 2.4 | 12/9/2021 | |
| 2.5 | The First Amendment to the Transaction and Combination Agreement between Foresight Acquisition Corp., the Merger Corps, the Blockers, Splitter and the Blocker Sellers. | 8-K | 001-40033 | 2.5 | 12/9/2021 | |
| 3.1 | Amended and Restated Certificate of Incorporation of the Company. | 8-K | 001-40033 | 3.1 | 12/9/2021 | |
| 3.2 | Amended and Restated Bylaws of the Company. | 8-K | 001-40033 | 3.1 | 3/12/2024 | |
| 10.1 | Unsecured Promissory Note, by and between P3 Health Group, LLC and VBC Growth SPV 2, LLC. | 8-K | 001-40033 | 10.1 | 3/28/2024 | |
| 10.2 | Subordination Agreement, by and among P3 Health Group, LLC, CRG Servicing LLC and VBC Growth SPV 2, LLC. | 8-K | 001-40033 | 10.2 | 3/28/2024 | |
| 10.3 | Fourth Amendment to Term Loan Agreement, by and among P3 Health Group, LLC, the subsidiary guarantors party thereto, the lenders party thereto and CRG Servicing LLC. | 8-K | 001-40033 | 10.3 | 3/28/2024 | |
| 10.4 | Consent, by and between P3 Health Group, LLC and VBC Growth SPV LLC. | 8-K | 001-40033 | 10.4 | 3/28/2024 | |
| 31.1 | * | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2 | * | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1 | ** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.2 | ** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS | * | Inline XBRL Instance Document | ||||
| 101.SCH | * | Inline XBRL Taxonomy Extension Schema Document | ||||
| ExhibitNumber | Description | Incorporated by Reference | |||
| Form | File No. | Exhibit | Filing Date | ||
| 101.CAL | * | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||
| 101.DEF | * | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||
| 101.LAB | * | Inline XBRL Taxonomy Extension Label Linkbase Document | |||
| 101.PRE | * | Inline XBRL Taxonomy Extension Presentation Document | |||
| 104 | * | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||
| * | Filed herewith |
|---|---|
| ** | Furnished herewith |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.